Dario A. Paggiarino, Chief Medical Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 98,599 shares at $25.41 ($2.5M) on 2024-01-26, disclosed to the SEC on 2024-01-30.
Scheduled sale ($2.5M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.41 | 51 | $1K | 0.1% |
| 2 | $25.41 | 15,609 | $397K | 15.7% |
| 3 | $25.41 | 15,609 | $397K | 15.7% |
| 4 | $25.77 | 33,665 | $868K | 34.3% |
| 5 | $25.77 | 33,665 | $868K | 34.3% |
| Total | $25.66 avg | 98,599 |
| $2.5M |
| 100% |
| Filing → |
| EYPT | SELL | 2024-01-10 | $968K | — | Filing → |
| EYPT | SELL | 2023-12-15 | $29K | — | Filing → |
| EYPT | SELL | 2023-12-06 | $674K | — | Filing → |